AlphaFold predicted structure
LHX2 · P50458

Mean pLDDT
65.6/ 100
Low
406 residues
Confidence breakdown
- Very high(≥ 90)29%
- Confident(70–90)17%
- Low(50–70)10%
- Very low(< 50)44%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
LIM homeobox 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownOptic neuropathy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownSevere microcephaly
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedneurodegenerative disease
neurodevelopmental disorder
hair color
complex neurodevelopmental disorder
type 2 diabetes mellitus
alcohol drinking
ankylosing spondylitis
adolescent idiopathic scoliosis
non-small cell lung carcinoma
nasopharyngeal carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
LIM/homeobox protein Lhx2
Acts as a transcriptional activator. Stimulates the promoter of the alpha-glycoprotein gene. Transcriptional regulatory protein involved in the control of cell differentiation in developing lymphoid and neural cell types (By similarity)
LHX2 · P50458

Mean pLDDT
65.6/ 100
Low
406 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0